Holdings (Monthly)
Guide ↗
Fidelity Advisor Biotechnology Fund
· Fidelity Advisor Series VII| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | 00287Y109 | Apr 2024 | 1,389,580 | $309.9M | 16.61% | EC |
| 2 | GILEAD SCIENCES INC | 375558103 | Jan 2026 | 864,100 | $122.7M | 6.57% | EC |
| 3 | ALNYLAM PHARMACEUTICALS INC | 02043Q107 | Apr 2024 | 277,186 | $93.7M | 5.02% | EC |
| 4 | ASCENDIS PHARMA A/S | 04351P101 | Apr 2024 | 370,625 | $83.8M | 4.49% | EC |
| 5 | COGENT BIOSCIENCES INC | 19240Q201 | Apr 2024 | 1,988,418 | $71.4M | 3.83% | EC |
| 6 | ARGENX SE | 04016X101 | Apr 2024 | 81,000 | $68.1M | 3.65% | EC |
| 7 | Fidelity Revere Street Trust | 31635A303 | Apr 2024 | 66,938,144 | $66.9M | 3.59% | STIV |
| 8 | INSMED INC | 457669307 | Apr 2024 | 412,300 | $64.7M | 3.47% | EC |
| 9 | VIRIDIAN THERAPEUTICS INC | 92790C104 | Apr 2024 | 1,782,464 | $58.8M | 3.15% | EC |
| 10 | BIOGEN INC | 09062X103 | Jan 2026 | 294,100 | $52.9M | 2.84% | EC |
| 11 | AMGEN INC | 031162100 | Apr 2024 | 150,703 | $51.5M | 2.76% | EC |
| 12 | VAXCYTE INC | 92243G108 | Apr 2024 | 796,329 | $42.7M | 2.29% | EC |
| 13 | STRUCTURE THERAPEUTICS INC | 86366E106 | Apr 2024 | 481,200 | $42.6M | 2.28% | EC |
| 14 | NUVALENT INC | 670703107 | Apr 2024 | 412,264 | $42.4M | 2.27% | EC |
| 15 | DIANTHUS THERAPEUTICS INC | 252828108 | Apr 2024 | 730,062 | $39.0M | 2.09% | EC |
| 16 | AMYLYX PHARMACEUTICALS INC | 03237H101 | Jan 2026 | 2,433,200 | $34.8M | 1.86% | EC |
| 17 | MODERNA INC | 60770K107 | Jan 2026 | 674,300 | $29.7M | 1.59% | EC |
| 18 | APOGEE THERAPEUTICS INC | 03770N101 | Apr 2024 | 452,639 | $29.7M | 1.59% | EC |
| 19 | XENON PHARMACEUTICALS INC | 98420N105 | Apr 2024 | 710,758 | $29.1M | 1.56% | EC |
| 20 | CRINETICS PHARMACEUTICALS INC | 22663K107 | Apr 2024 | 544,470 | $27.2M | 1.46% | EC |
| 21 | PRAXIS PRECISION MEDICINES INC. | 74006W207 | Jan 2026 | 86,400 | $27.1M | 1.45% | EC |
| 22 | SCHOLAR ROCK HOLDING CORP | 80706P103 | Apr 2024 | 582,368 | $25.8M | 1.38% | EC |
| 23 | ORUKA THERAPEUTICS INC | 687604108 | Jan 2026 | 710,786 | $24.3M | 1.30% | EC |
| 24 | SPYRE THERAPEUTICS INC | 00773J202 | Apr 2024 | 749,342 | $24.0M | 1.28% | EC |
| 25 | UCB SA | N/A | Apr 2024 | 75,800 | $22.9M | 1.23% | EC |
| 26 | UNIQURE N.V. | N/A | Apr 2024 | 991,600 | $22.5M | 1.21% | EC |
| 27 | UPSTREAM BIO INC | 91678A107 | Jan 2026 | 691,003 | $21.5M | 1.15% | EC |
| 28 | ROIVANT SCIENCES LTD | N/A | Apr 2024 | 976,200 | $21.1M | 1.13% | EC |
| 29 | NATERA INC | 632307104 | Jan 2026 | 89,400 | $20.7M | 1.11% | EC |
| 30 | OLEMA PHARMACEUTICALS INC | 68062P106 | Jan 2026 | 782,800 | $20.1M | 1.08% | EC |
| 31 | VIKING THERAPEUTICS INC | 92686J106 | Apr 2024 | 647,387 | $18.8M | 1.01% | EC |
| 32 | NEWAMSTERDAM PHARMA COMPANY NV | N/A | Apr 2024 | 586,400 | $18.2M | 0.98% | EC |
| 33 | CYTOKINETICS INC | 23282W605 | Apr 2024 | 283,071 | $17.9M | 0.96% | EC |
| 34 | KYMERA THERAPEUTICS INC | 501575104 | Apr 2024 | 231,700 | $16.8M | 0.90% | EC |
| 35 | JADE BIOSCIENCES INC | 008064206 | Jan 2026 | 894,343 | $14.0M | 0.75% | EC |
| 36 | CG ONCOLOGY INC | 156944100 | Jan 2026 | 248,900 | $13.0M | 0.69% | EC |
| 37 | RHYTHM PHARMACEUTICALS INC | 76243J105 | Jan 2026 | 126,200 | $12.9M | 0.69% | EC |
| 38 | ENLIVEN THERAPEUTICS INC | 29337E102 | Apr 2024 | 474,262 | $12.5M | 0.67% | EC |
| 39 | ZENAS BIOPHARMA INC | 98937L105 | Jan 2026 | 629,316 | $11.6M | 0.62% | EC |
| 40 | DISC MEDICINE INC | 254604101 | Jan 2026 | 142,322 | $11.0M | 0.59% | EC |
| 41 | ARCELLX INC | 03940C100 | Apr 2024 | 142,900 | $9.8M | 0.52% | EC |
| 42 | STOKE THERAPEUTICS INC | 86150R107 | Jan 2026 | 317,700 | $9.6M | 0.52% | EC |
| 43 | TRAVERE THERAPEUTICS INC | 89422G107 | Jan 2026 | 301,200 | $9.4M | 0.50% | EC |
| 44 | MINERALYS THERAPEUTICS INC | 603170101 | Jan 2026 | 266,800 | $8.2M | 0.44% | EC |
| 45 | CYTOMX THERAPEUTICS INC | 23284F105 | Jan 2026 | 1,350,251 | $7.7M | 0.41% | EC |
| 46 | ANAPTYSBIO INC | 032724106 | Apr 2024 | 148,400 | $7.0M | 0.38% | EC |
| 47 | SOLENO THERAPEUTICS INC | 834203309 | Jan 2026 | 181,000 | $7.0M | 0.37% | EC |
| 48 | CELLDEX THERAPEUTICS INC | 15117B202 | Apr 2024 | 275,652 | $6.8M | 0.36% | EC |
| 49 | REZOLUTE INC | 76200L309 | Jan 2026 | 1,985,100 | $6.6M | 0.36% | EC |
| 50 | ANNEXON INC | 03589W102 | Apr 2024 | 1,005,200 | $6.3M | 0.34% | EC |
| 51 | SONOMA BIOTHERAPEUTICS INC | N/A | Apr 2024 | 1,967,762 | $5.9M | 0.32% | EP |
| 52 | Fidelity Revere Street Trust | 31635A105 | Apr 2024 | 5,792,224 | $5.8M | 0.31% | STIV |
| 53 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | N/A | Apr 2024 | 130,476 | $5.7M | 0.31% | EC |
| 54 | MAZE THERAPEUTICS INC | 578784100 | Jan 2026 | 128,000 | $5.6M | 0.30% | EC |
| 55 | X4 PHARMACEUTICALS INC | 98420X202 | Jan 2026 | 1,341,800 | $5.0M | 0.27% | EC |
| 56 | SUMMIT THERAPEUTICS INC | 86627T108 | Jan 2026 | 329,400 | $4.8M | 0.26% | EC |
| 57 | TANGO THERAPEUTICS INC | 87583X109 | Apr 2024 | 403,626 | $4.7M | 0.25% | EC |
| 58 | JANUX THERAPEUTICS INC | 47103J105 | Apr 2024 | 320,385 | $4.4M | 0.24% | EC |
| 59 | RAPPORT THERAPEUTICS INC | 75383L102 | Jan 2026 | 156,946 | $4.2M | 0.22% | EC |
| 60 | MBX BIOSCIENCES INC | 55287L101 | Jan 2026 | 111,100 | $4.1M | 0.22% | EC |
| 61 | TENAX THERAPEUTICS INC | 88032L605 | Jan 2026 | 322,600 | $4.0M | 0.22% | EC |
| 62 | WAVE LIFE SCIENCES LTD | N/A | Apr 2024 | 289,700 | $3.7M | 0.20% | EC |
| 63 | SONOMA BIOTHERAPEUTICS INC | N/A | Apr 2024 | 1,049,456 | $3.5M | 0.19% | EP |
| 64 | BRIGHT PEAK THERAPEUTICS INC. | N/A | Apr 2024 | 1,920,122 | $3.4M | 0.18% | EP |
| 65 | ENDEAVOR BIOMEDICINES INC | N/A | Apr 2024 | 526,643 | $3.4M | 0.18% | EP |
| 66 | AVALO THERAPEUTICS INC | 05338F306 | Jan 2026 | 220,300 | $3.3M | 0.18% | EC |
| 67 | KARTOS THERAPEUTICS INC | N/A | Apr 2024 | 530,692 | $3.2M | 0.17% | EP |
| 68 | PARABILIS MEDICINES INC | N/A | Apr 2024 | 491,600 | $3.0M | 0.16% | EP |
| 69 | GALECTO INC | N/A | Apr 2024 | 100 | $2.6M | 0.14% | EP |
| 70 | TECTONIC THERAPEUTIC INC | 878972108 | Jan 2026 | 120,995 | $2.4M | 0.13% | EC |
| 71 | CRESCENT BIOPHARMA INC | N/A | Apr 2024 | 251,090 | $2.4M | 0.13% | EC |
| 72 | DEFINIUM THERAPEUTICS INC | 24477V105 | Jan 2026 | 141,900 | $2.4M | 0.13% | EC |
| 73 | LIFEMINE THERAPEUTICS INC | N/A | Apr 2024 | 1,950,028 | $2.3M | 0.12% | EP |
| 74 | FABIO TUB HOLDINGS LLC | N/A | Apr 2024 | 6,300 | $2.3M | 0.12% | EC |
| 75 | CENTESSA PHARMACEUTICALS PLC | 152309100 | Jan 2026 | 83,600 | $2.1M | 0.11% | EC |
| 76 | MENTARI THERAPEUTICS INC | N/A | Apr 2024 | 1,457,407 | $2.0M | 0.11% | EP |
| 77 | ASTRIA THERAPEUTICS INC | N/A | Apr 2024 | 247,630 | $2.0M | 0.11% | EC |
| 78 | ENLIVEN THERAPEUTICS INC | N/A | Apr 2024 | 73,200 | $1.9M | 0.10% | EC |
| 79 | CANDID THERAPEUTICS | N/A | Apr 2024 | 1,500,060 | $1.8M | 0.10% | EP |
| 80 | CARDURION PHARMACEUTICALS INC | N/A | Apr 2024 | 331,596 | $1.8M | 0.09% | EP |
| 81 | PARABILIS MEDICINES INC | N/A | Apr 2024 | 239,281 | $1.8M | 0.09% | EP |
| 82 | ZENAS BIOPHARMA INC | N/A | Apr 2024 | 86,234 | $1.6M | 0.08% | EC |
| 83 | INOVIO PHARMACEUTICALS INC | 45773H409 | Jan 2026 | 883,081 | $1.4M | 0.08% | EC |
| 84 | BRIGHT PEAK THERAPEUTICS INC. | N/A | Apr 2024 | 873,604 | $1.1M | 0.06% | EP |
| 85 | CRESCENT BIOPHARMA INC | N/A | Apr 2024 | 98,300 | $943K | 0.05% | EC |
| 86 | WUGEN INC | N/A | Apr 2024 | 580,277 | $923K | 0.05% | EP |
| 87 | ORUKA THERAPEUTICS INC | N/A | Apr 2024 | 26,600 | $911K | 0.05% | EC |
| 88 | T-KNIFE THERAPEUTICS INC | N/A | Apr 2024 | 1,300,097 | $897K | 0.05% | EP |
| 89 | WUGEN INC | N/A | Apr 2024 | 831,313 | $881K | 0.05% | DBT |
| 90 | TREELINE BIOSCIENCES | N/A | Apr 2024 | 47,600 | $402K | 0.02% | EP |
| 91 | AFFERENT PHARMA | N/A | Apr 2024 | 1,915,787 | $19 | 0.00% | EP |
| 92 | ENLIVEN THERAPEUTICS INC | 2226681D | Apr 2024 | 739,725 | $7 | 0.00% | EC |